This is a hub for BioWorld publications. Covers the biotechnology industry worldwide.

BioWorld International is a global intelligence service that brings you news on international strategic deals, worldwide investment opportunities, country-by-country regulatory issues, product development and insight on emerging biotech companies. Delivered every Wednesday, BioWorld International will keep you informed on international strategic alliances, worldwide investment opportunities, global regulatory issues and more. Available via fax, online and e-mail. Published by Thomson.

Published for the medical device industry with information such as new product developments, company news, regulatory activity, legislative actions, strategic alliances, sales and mergers and market updates. Please direct all press materials to the main email, this email file is checked on a daily basis.

BioWorld MedTech Online is aimed at the medical device industry with information such as new product developments, company news, regulatory activity, legislative actions, strategic alliances, sales and mergers and market updates.

BioWorld Science is a daily newsletter covering drug discovery and development news. Includes News, Conference Highlights, and Industry People.

Addresses the immediate needs of biotechnology professionals and investors who desire comprehensive coverage of the latest news. The magazine also covers the business and science of biopharmaceuticals - company financials, mergers and acquisitions, collaborations and licensing deals, VC funding, technology transfers and executive moves. It also covers financings, deals, FDA approvals, trial initiations, preclinical and clinical data, regulatory news, commercial biotech earnings, conferences and new companies. The magazine does not cover diagnostics or medical devices unless they are specifically related to the development of a biopharmaceutical. The publication has news meetings daily at 10 a.m. EST and the daily copy deadline is 4:30 p.m. EST. BioWorld editors also attend industry events such as BIO International and the JP Morgan Healthcare Conference as well as the major medical meetings. For regulatory news, pitch the Washington Editor. For publications or presentations of early stage research, pitch the Science Editor. For trends and analysis appropriate for BioWorld Insight, pitch the Insight Editor. They are otherwise beat-agnostic. As mentioned, news can always be sent to newsdesk@bioworld.com – this account is monitored throughout business hours. The BioWorld Today editorial news meeting happens daily at 10 a.m. EST. That’s when they pick the stories for the day, so if you have news that’s complex and needs explanation (i.e. a deal with no terms, but an interesting structure), please reach out to them before then. Their daily copy deadline (the time when stories must be completed by our writers) is 4:30 p.m. EST. The Publication ask that all press releases be sent to, or at least copied to the main email.

Addresses the immediate needs of biotechnology professionals and investors who desire comprehensive coverage of the latest news. The magazine also covers the business and science of biopharmaceuticals - company financials, mergers and acquisitions, collaborations and licensing deals, VC funding, technology transfers and executive moves. It also covers financings, deals, FDA approvals, trial initiations, preclinical and clinical data, regulatory news, commercial biotech earnings, conferences and new companies. The magazine does not cover diagnostics or medical devices unless they are specifically related to the development of a biopharmaceutical. The publication has news meetings daily at 10 a.m. EST and the daily copy deadline is 4:30 p.m. EST. BioWorld editors also attend industry events such as BIO International and the JP Morgan Healthcare Conference as well as the major medical meetings. For regulatory news, pitch the Washington Editor. For publications or presentations of early stage research, pitch the Science Editor. For trends and analysis appropriate for BioWorld Insight, pitch the Insight Editor. They are otherwise beat-agnostic. As mentioned, news can always be sent to newsdesk@bioworld.com – this account is monitored throughout business hours. The BioWorld Today editorial news meeting happens daily at 10 a.m. EST. That’s when they pick the stories for the day, so if you have news that’s complex and needs explanation (i.e. a deal with no terms, but an interesting structure), please reach out to them before then. Their daily copy deadline (the time when stories must be completed by our writers) is 4:30 p.m. EST. The Publication ask that all press releases be sent to, or at least copied to the main email.

BioXconomy is a digital publication by Informa, delivering insights and trends which are shaping the biopharma industry.

bip (formerly America's Benefit Specialist), is the official publication of National Association of Benefits and Insurance Professionals - NABIP (formerly The National Association of Health Underwriters - NAHU), Edited for health insurance agents and managers, brokers, personnel and marketing management. Features articles on industry trends, technology, legislation, association news, products and services.

“Bipodisan,” is a podcast in which opposites respectfully talk, not shout, about the issues dividing America!